We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 269

Study Finds Link Between Concussions in Adolescents and Risk of Multiple Sclerosis
  • Stark & Stark
  • USA
  • November 6 2017

A recent study found that concussions in adolescents can increase the risk of developing multiple sclerosis (MS) later in life. The risk increased


CNN Investigates Expanding Use of Nuedexta in Nursing Homes
  • Stark & Stark
  • USA
  • October 16 2017

A recent investigation by CNN brought to light the expanding and allegedly inappropriate use of the prescription drug Nuedexta in nursing homes


No Summer Breaks for the EEOC
  • Kelley Drye & Warren LLP
  • USA
  • September 19 2017

As many of us settle into September, with fond memories of our summer vacations, do not think that the federal agencies were on a hiatus. In fact and


Governor Kasich Signs Bill to Legalize Marijuana for Medicinal Use in Ohio
  • Dickinson Wright
  • USA
  • July 6 2017

On June 8, 2016, Governor John R. Kasich signed into law HB 523, which legalizes marijuana in Ohio for specified medicinal purposes. The bill moved


Florida Enacts Law to Implement Provisions of its Medical Marijuana Amendment, but Significant Questions Remain for Employers
  • Ford & Harrison LLP
  • USA
  • June 30 2017

Late last week Florida Governor Rick Scott signed into law a bill intended to implement provisions of the medical marijuana constitutional amendment


New Jersey Federal Court Rejects Expansion of Negligent Undertaking Liability
  • Dechert LLP
  • USA
  • April 25 2017

When this blogger hears "negligent undertaking," my mind does not automatically turn to products liability - but rather to pre-teen children. Pre-teen


Denied Petition Grounds May Be Relevant to PTAB Trial
  • Oblon
  • USA
  • April 17 2017

CAFC Emphasizes that Art of Denied Petition Grounds Can Come Back to Haunt Patentees It is not uncommon for an AIA Trial Proceeding, such as Inter


Federal Circuit Affirms Obviousness of Novartis’s Patent for Multiple Sclerosis Drug
  • Knobbe Martens
  • USA
  • April 17 2017

The Federal Circuit affirmed the PTAB’s final written decision holding that claims directed to Novartis’s multiple sclerosis drug Gilenya were obvious


Genentech and Roche Secure FDA Approval of Multiple Sclerosis Drug Ocrevus
  • Knobbe Martens
  • USA
  • April 10 2017

On March 28, 2017, the U.S. Food and Drug Administration (FDA) approved the use of Ocrevus (ocrelizumab) in treating multiple sclerosis (MS). Ocrevus


CFAD Fails to Knock Out 4 Acorda Patents to Multiple Sclerosis Drug
  • Marshall Gerstein & Borun LLP
  • USA
  • April 10 2017

A recent set of final written decisions in four IPRs against Acorda Therapeutics puts more marks in the loss column for Kyle Bass and the Coalition